BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3648 related articles for article (PubMed ID: 17981482)

  • 21. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S; Mallick SK; Bose S
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
    Song W; Lee KM; Kim HS; Kim JS; Kim J; Jeong SH; Roh KH
    Int J Antimicrob Agents; 2006 Dec; 28(6):520-4. PubMed ID: 17095195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin.
    Grover SS; Sharma M; Chattopadhya D; Kapoor H; Pasha ST; Singh G
    J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals.
    Yan JJ; Wu JJ; Ko WC; Tsai SH; Chuang CL; Wu HM; Lu YJ; Li JD
    J Antimicrob Chemother; 2004 Dec; 54(6):1007-12. PubMed ID: 15486082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
    Coşkun S; Altanlar N
    Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
    Oksüz L; Gürler N
    Mikrobiyol Bul; 2009 Apr; 43(2):183-94. PubMed ID: 19621602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
    Baykal A; Cöplü N; Simşek H; Esen B; Gür D
    Mikrobiyol Bul; 2012 Apr; 46(2):159-69. PubMed ID: 22639305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
    Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
    J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
    J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of extended spectrum beta-lactamases producing clinical isolates from patients of urinary tract infection in a tertiary care hospital in Delhi.
    Malhotra VL; Khandpur N; Dass A; Mehta G
    J Commun Dis; 2008 Dec; 40(4):269-72. PubMed ID: 19579719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
    Vo AT; van Duijkeren E; Fluit AC; Gaastra W
    Vet Microbiol; 2007 Oct; 124(3-4):248-55. PubMed ID: 17521833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
    Liao CH; Sheng WH; Wang JT; Sun HY; Wang HK; Hsueh PR; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2006 Feb; 39(1):59-66. PubMed ID: 16440125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark.
    Kjerulf A; Hansen DS; Sandvang D; Hansen F; Frimodt-Møller N
    APMIS; 2008 Feb; 116(2):118-24. PubMed ID: 18321362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriuria by extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran.
    Aminzadeh Z; Sadat Kashi M; Sha'bani M
    Iran J Kidney Dis; 2008 Oct; 2(4):197-200. PubMed ID: 19377237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.
    Yu Y; Zhou W; Chen Y; Ding Y; Ma Y
    Chin Med J (Engl); 2002 Oct; 115(10):1479-82. PubMed ID: 12490091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 183.